PPS-001
Undisclosed Oncology
PreclinicalActive
Key Facts
About PeptiDream
PeptiDream is a leader in peptide drug discovery, utilizing its innovative PDPS technology to generate diverse, non-standard peptide libraries for identifying drug candidates against 'undruggable' targets. The company has established a highly successful business model based on research collaborations and licensing agreements with global pharmaceutical giants, generating significant non-dilutive funding. Its internal and partnered pipeline spans multiple therapeutic areas, with several candidates in clinical development. PeptiDream's strategy focuses on expanding its platform's reach and advancing key proprietary assets toward commercialization.
View full company profileTherapeutic Areas
Other Undisclosed Oncology Drugs
| Drug | Company | Phase |
|---|---|---|
| NS-0100 | Nippon Shinyaku | Preclinical |
| BRM Selective Program | Foghorn Therapeutics | Discovery |